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Abstract 
Objective. Acceptance and Commitment Therapy, Mindfulness-Based Cognitive Therapy and 
Problem-Solving Therapy are types of Cognitive Behavioural Therapy (CBT) group that 
improve physical and mental health in chronic pain or cancer. However, dropout is high due 
to group demands alongside physical impairments. Motivational interviewing (MI) is a well-
evidenced means of enhancing treatment adherence. Few studies have investigated MI as an 
adjunct to CBT in cancer or chronic pain and none have established the minimum MI 
duration required for adherence improvement. This study evaluated minimal-duration MI to 
improve adherence in three CBT group-types for cancer and chronic pain.  
Methods. In a cohort study of 99 cancer and chronic pain patients, 47 were given a 10–15-
minute structured MI telephone intervention (MI-call) after the first session. The remaining 
52 received a CBT group without MI (no-MI).  
Results. Odds of completing group CBTs were 5 times greater for patients in the MI-call 
cohort versus no-MI. Effects remained when controlling for age, gender, diagnosis, group-
type and baseline quality of life. The MI-call cohort attended one extra session per patient 
compared to no-MI, controlling for age, gender and diagnosis.  
Conclusions. A brief MI telephone intervention may improve adherence to group CBTs in 
cancer and chronic pain. 
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Reducing Dropout in Acceptance and Commitment Therapy, Mindfulness Based-
Cognitive Therapy and Problem-Solving Therapy for Chronic Pain and Cancer Patients 
Using Motivational Interviewing 
 Acceptance and Commitment Therapy (ACT), Mindfulness Based Cognitive Therapy 
(MBCT) and Problem-Solving Therapy (PST) are three types of Cognitive-Behavioural 
therapy (CBT) that are shown to have a range of benefits for cancer and chronic pain patients. 
Among cancer patients, MBCT led to improvements in quality of life and several symptoms 
related to cancer treatment, alongside indications of cost effectiveness (Haller et al., 2017; 
Johannsen, Sørensen, O'Connor, Jensen, & Zachariae, 2017). Health and quality of life was 
also improved with PST for cancer patients, even those with poor prognosis (Sharpe et al., 
2014; Strong et al., 2008; Walker et al., 2014). In chronic pain, ACT is shown to have 
medium-to-large effects on pain acceptance and smaller effects on pain intensity and 
interference, alongside positive impacts on mental health and functioning (Feliu-Soler et al., 
2018; Hann & McCracken, 2014; Hughes, Clark, Colclough, Dale, & McMillan, 2017).  
 The theoretical premise of ACT, MBCT and PST in long-term conditions emphasizes 
the damaging effect that can emerge from problematic reactions to cancer and chronic pain 
symptoms, rather than aiming to change the symptoms themselves (Hayes, Follette, & 
Linehan, 2004). Therefore, treatment focuses on developing a valued life alongside cancer or 
chronic pain, rather than a life spent trying to rid oneself of the symptoms associated with 
these illnesses. Group delivery is often preferred in all three therapies for cancer and chronic 
pain patients because it also addresses the isolation often experienced by people with these 
problems (Karayannis, Baumann, Sturgeon, Melloh, & Mackey, 2018; Macmillan Cancer 
Support, 2013).  
 However, the effectiveness of psychological therapies for cancer and chronic pain 
patients is limited by dropout, with recent evidence suggesting dropout rates of up to 50% 
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from CBT-based interventions in both conditions (Nicholas et al., 2012; Nicholas et al., 2014; 
Tickell et al., 2019). Furthermore, group psychological therapies have higher dropout rates 
than one-to-one programmes in general (Fernandez, Salem, Swift, & Ramtahal, 2015; Swift 
& Greenberg, 2012). Specifically, MBCT and PST can have higher dropout rates than group 
psychological therapies in general (Carlson et al., 2016; Cuijpers, van Straten, & 
Warmerdam, 2007; Schellekens et al., 2017; Swift & Greenberg, 2014). Reported ACT 
dropout rates have typically focused on one-to-one formats, but questions have been raised as 
to whether dropout is greater in group formats (Feliu-Soler et al., 2018). Overall, the 
accessibility and effectiveness of, MBCT, PST and ACT groups for cancer and chronic pain 
could be enhanced if dropout rates could be reduced. 
 Motivational Interviewing (MI) is a well-evidenced means of reducing dropout when 
used as an adjunct to group or individual CBT for mental health problems such as anxiety 
(Barrera, Smith, & Norton, 2016; Westra, Constantino, & Antony, 2016). It is also shown to 
improve adherence when used as an adjunct to medical treatments (e.g. Palacio et al., 2016). 
Motivational Interviewing is a person-centred counselling method that uses empathic and 
reflective interpersonal skills to manage patient resistance and elicit motivation for health 
behaviour change by resolving ambivalence about change (Miller & Rollnick, 2012). The 
approach is relevant to dropout from ACT, MBCT and PST, because motivation is a 
recognized factor influencing treatment adherence and retention (Antony, Ledley, & 
Heimberg, 2005). Therefore, MI could help patients with long-term conditions, such as 
cancer and chronic pain, to resolve ambivalence about engagement with an effortful, 
challenging treatment that is presented at a time when they may be suffering the physical and 
mental strain of disease (Demark-Wahnefried, Aziz, Rowland, & Pinto, 2005; Lawson & 
Flocke, 2009) 
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 Although there is evidence for the use of MI as an effective standalone treatment in 
both cancer and chronic pain, there is little current evidence for the use of MI in conjunction 
with ACT, MBCT or PST groups in these populations (Alperstein & Sharpe, 2016; Spencer 
& Wheeler, 2016). Furthermore, it is unclear what minimum duration of MI is required for a 
clinically meaningful effect, as different studies have ranged from one to four or more hour-
long sessions of MI added to CBT (Barrera et al., 2016; Westra, Arkowitz, & Dozois, 2009; 
Westra et al., 2016). Consequently, it is possible that clinically important effects might be 
gained from even a very small duration of MI, but the necessary amount of MI is currently 
unknown. If small durations of MI can suffice, integration with CBT-type groups might 
represent an easily implemented and cost-effective means of reducing group-dropout. This is 
noteworthy, because other, much less resource-intensive interventions (such as giving 
patients choice of appointment time or therapist) can have similar effects on treatment 
retention as several MI sessions (Oldham, Kellett, Miles, & Sheeran, 2012). Therefore, 
maximizing the efficiency of MI would help clarify whether it is truly comparable to other 
dropout-prevention interventions in terms of cost-effectiveness. 
 Most research on MBCT, PST, ACT and MI in cancer and chronic pain has been 
under experimental research conditions. This is important because dropout rates are typically 
higher in routine care settings than in controlled research trials (Hansen, Lambert, & Forman, 
2002; NHS Digital, 2018). Furthermore, research trial participants are often significantly 
different from patients seen in routine practice in the severity and range of presentations 
(Barnish & Turner, 2017; Fortin et al., 2006). Therefore, dropout rates from research trials 
may underestimate the prevalence of this problem in clinical practice, making it harder to 
evaluate the effects that associated interventions may have. 
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The Present Study  
 Overall, current evidence suggests that a significant proportion of patients attending 
MBCT, PST and ACT groups for cancer and chronic pain drop out prematurely and do not, 
therefore, receive the full benefit they might if they completed their programme. Adjunctive 
MI may ameliorate this important problem but is as yet untested in these populations or any 
type of group CBT. It is also unclear how small the duration of MI can be for clinically 
important effects or whether current evidence for the integration of MI with CBT carries 
through from controlled research to clinical practice. This study evaluates the use of a 
minimal duration of MI as an adjunct to three types of CBT group for cancer and chronic 
pain patients in a routine care setting. This study aimed to assess whether the addition of a 
10–15-minute MI telephone call reduced dropout from group MBCT and PST for cancer, and 
group ACT for chronic pain. 
Method 
Participants 
 Of the 99 participants, 52 were in the no-MI cohort and 47 in the MI-call cohort. 
Forty-six were cancer patients attending MBCT (no-MI = 22; MI-call = 24); 27 were cancer 
patients attending PST (no-MI = 14; MI-call = 13), and 26 were chronic pain patients 
attending ACT (no-MI = 16; MI-call = 10). All participants had been referred to a clinical 
psychology service in an acute NHS hospital setting in the UK. Cancer patients were referred 
by members of their treating cancer care team, including clinical nurse specialists, treating 
surgeons, or oncologists. Cancer patients received a screening assessment from a clinical 
psychologist face-to-face or by telephone. Among cancer patients, allocation to either MBCT 
or PST was determined on group availability, waiting time, and the presence of rumination as 
a key presenting problem – that is, repeated mental rehearsal of events either from the past or 
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anticipated in the future, with little sense of control or progress (Nolen-Hoeksema, 2000). If 
rumination was assessed to be a key presenting problem, patients were offered MBCT. 
 Chronic pain patients were referred to the same clinical psychology service from a 
multi-disciplinary chronic pain team, typically via specialist pain nurses or treating 
anaesthetists. Referred patients were offered a one-to-one assessment after an open 
information session where a decision was made about suitability for group-based ACT or 
one-to-one ACT if this was not deemed appropriate or feasible, based on either clinical 
judgement or patient preference. 
Design 
 A non-randomized cohort study was conducted with consecutive MBCT and PST 
groups for cancer patients and ACT groups for chronic pain patients. One patient cohort was 
comprised of those attending at least the first session of a CBT group programme and offered 
a 10-15 minute structured MI-based telephone intervention after the first session (MI-call). 
The other cohort included those attending the first session of a CBT group and not offered 
this intervention (no-MI). Group attendance and clinical effectiveness was then compared 
between groups controlling for key demographic and clinical characteristics. 
Therapists 
 The MBCT groups were all led by the same two clinical psychologists (JL and SM) 
who had received standardized training in MBCT delivery and had adherence monitored by 
an experienced MBCT supervisor using video recordings of sessions. The PST groups were 
each led by one of two clinical psychologists (SB and NP) and one of two cancer support 
staff. All PST group leaders had been trained using the same nationally standardized 
methods. PST therapists were observed and assessed by an established programme leader. All 
ACT for pain groups were led by the same two clinical psychologists (JR and WV). Both had 
REDUCING DROPOUT IN CANCER AND PAIN                                                               9 
received specialist training in the use of ACT for chronic pain. No therapists facilitated more 
than one group-type.  
Treatments 
 MBCT. The original eight-session MBCT programme (Segal, Williams, & Teasdale, 
2013) was adapted to cancer care using an established treatment protocol (Bartley, 2012). 
Each treatment session included a new type of mindfulness practice, aimed at training non-
judgmental awareness of the present moment and facilitating meaningful responses to 
moment-by-moment experiences. This included group reflection on the experience of each 
practice and 30-40 minute daily home practice between sessions.  Cancer-related adaptations 
meant that each session was 2.5 hours long with breaks and space to opt in or out of all 
activities, dependent on physical limitations. 
 PST. A range of CBT interventions were tailored to patients experiencing cancer in 
six weekly group sessions of 2.5 hours each including a break using a nationally delivered 
programme (Turner & Martin, 2017). The protocol was based on PST methods shown to be 
clinically effective in improving quality of life in cancer care (Sharpe et al., 2014; Strong et 
al., 2008; Walker et al., 2014). This included problem-solving techniques, goal setting and 
behavioural activation related to common difficulties experienced by cancer patients. Each 
session included homework tasks where new techniques were tested out during the week.  
 ACT. An established ACT for chronic pain programme was adapted from a two week 
group including four sessions of four hours, to eight weekly sessions of two hours each 
(McCracken, Sato, & Taylor, 2013). This aimed to make the group more accessible to 
chronic pain community outpatients. Adaptations also meant that weekly homework could 
help patients to apply learning to their personal environment and share methods for 
overcoming barriers to progress. As with the original program, the current ACT group 
combined information giving, experiential learning techniques, and metaphor to help 
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participants to identify and address unhelpful patterns of avoidance whilst committing to 
values-based action.  
 MI-call. The MI telephone intervention was carried out in the week following the first 
session of MBCT, PST, or ACT. The calls were made to those who attended the first session 
by an independent clinical psychologist within the clinical psychology service who was not 
the therapist for the programme attended. All MI-call therapists had received specialist 
training in MI, including practice of MI skills. The call had a set of overall intentions coupled 
with some specific MI-based techniques applied in a semi-structured manner. Therapists 
primarily aimed to convey an attitude which expressed openness and acceptance of whatever 
patients chose, with respect for the patient’s right to choose (Miller & Rollnick, 2012). 
Therapists were enabled to emphasize this attitude because they were not directly responsible 
for offering the treatment patients were considering. The intervention specifically intended to 
use reflections and summaries more than questioning. Summaries and reflections were used 
to draw out patients’ personal values and gain a sense of what really mattered to the patient 
that the group programme could help them with. The call also intended to focus on elicitation 
of hopes and potential benefits of the group to the individual patient, setting aside explaining 
or offering any benefits the therapist might feel patients could have. Lastly, the call aimed to 
acknowledge difficulties experienced by patients and if possible, agree a means of addressing 
them. The call explicitly aimed to minimize directing patient choice, unsolicited information-
giving, and confronting problematic health behaviours, particularly withdrawal from CBT 
groups. 
The call was opened with an introduction, typically explaining the purpose of the call: 
“Hi, I am calling from the clinical psychology service. You recently attended one of our 
groups and we recognize that keeping going with a group can be a challenge. So, I am 
REDUCING DROPOUT IN CANCER AND PAIN                                                               11 
one of the other clinical psychologists and I am calling to see how you found the group 
so far and what you would like to get out of it in the long-run.” 
The conversation was then semi-structured around a series of established MI questions: 
1. What hopes/concerns do you have for the group? 
2. What are the most important reasons for you to attend the group?  
3. Why are these things important to you? (summarize: “ So X is important to you”) 
4. What do you think would give you the best chance of success with the group?  
5. What do you imagine you will do? / How do you imagine you will approach the next 
session? 
At the end of the call the therapist summarized the key challenges involved in 
attending the group, the main personal reasons for the patient to attend, and the ways that 
patients identified for overcoming barriers (“the best chance of success”). The MI-call 
therapist then had no further direct input with the group attendees but fed back summaries of 
each call to the therapists leading the relevant group. 
Outcome Measures 
 Attendance. Where patients were present for any part of a session it was counted as 
attending. Using established criteria, attending four or more group sessions was categorized 
as treatment completion (Teasdale et al., 2001). 
 Cancer-Related Quality of Life. The Functional Assessment of Cancer Therapy – 
General 7-items (FACT-G7; Yanez, Pearman, Lis, Beaumont, & Cella, 2012) was used to 
assess quality of life specific to cancer patients. The FACT-G7 asks about the most important 
quality of life factors, as rated by cancer patients, which includes fatigue, sleep, pain, nausea, 
fear of recurrence and enjoyment of life using a five-point Likert scale (e.g. “I have lack of 
energy – not at all, a little bit, somewhat, quite a bit, very much”). It was administered pre- 
and post-treatment as the outcome in both MBCT and PST groups. The FACT-G7 has shown 
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good internal consistency (α = 0.74) and moderate-to-strong association with established 
quality of life assessments (rss = .60 to .89) (Yanez et al., 2012).  
 Chronic Pain Acceptance. The chronic pain acceptance questionnaire (CPAQ; 
McCracken, Vowles, & Eccleston, 2004) is a 20-item assessment of pain acceptance 
comprised of two sub-scales: pain willingness (absence of attempts to control pain) and  
activity engagement (performing desired activities in spite of pain). Seven-point Likert scales 
are used to rate each statement from “Never true” to Always true” (e.g. I am getting on with 
the business of living no matter what my level of pain is). The CPAQ was used as the pre-
post treatment outcome measure in the ACT for chronic pain group. Reneman, Dijkstra, 
Geertzen, and Dijkstra (2010) determined that the CPAQ showed superior psychometric 
properties compared to other assessments of pain acceptance, with good internal consistency 
(αs = .62 to .84) and negative associations with pain intensity, pain-related anxiety, and 
disability (rs = -0.66 to -0.28). 
Procedure 
 Data were collected from four PST, five MBCT, and three ACT groups between May 
2017 and July 2019. The no-MI cohort was composed of participants attending the two 
earlier PST groups, three earlier MBCT groups, and two earlier ACT groups. Group 
therapists had no awareness of the MI-call intervention during groups where it was not 
included as an intervention.  
 Participants’ attendance was recorded by therapists on arrival at the start of the 
session and amended at the end of the group if other participants joined part way through. 
Outcome measures were completed on arrival directly prior to the first session and directly 
prior to the final session (or at the end of the final session in the case of ACT). 
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Method of Analysis 
 Differences between MI-call and no-MI cohorts were assessed using Mann-Whitney-
U and chi square tests for continuous and categorical variables, respectively. Logistic 
regression was used to assess differences between MI-call and no-MI groups in completion 
rates controlling for a priori determined covariates: age, gender, diagnosis (cancer or chronic 
pain), and group type (PST, MBCT, or ACT). A one-way analysis of covariance (ANCOVA) 
was used to evaluate possible differences between MI-call and no-MI groups in the number 
of sessions attended, controlling for age, gender, diagnosis and group-type. As model 
residuals were slightly skewed, a 1,000 samples bootstrap was applied to give more reliable 
estimates for the 95% confidence interval. Cohen’s d was computed based on estimated 
marginal mean-differences and robust standard errors (0.20 ‘small’, 0.50 ‘medium’, 0.80 
‘large’). As cancer and chronic pain patients completed different outcome measures, a sub-
analysis including just cancer patients added baseline FACT-G7 as an additional (1) predictor 
in logistic regression for completion and (2) covariate in ANCOVA for number of sessions 
attended. To examine potential differences in clinical effectiveness between MI-call and no-
MI groups, separate analyses were run for cancer and chronic pain patients (focussing on the 
FACT-G7 and CPAQ respectively). MI group effects were assessed using ANCOVAs on 
post-treatment outcome scores controlling for baseline scores. Bootstrapping (1,000 samples) 
was again applied to account for skewed residuals. A diagnostic group-specific analysis was 
also completed for cancer patients using post-group FACT-G7 as outcome and MI-call and 
baseline score as predictors. Due to the small sample of completed outcomes in chronic pain 
groups, this sub-analysis could not be repeated with the CPAQ. Overall clinical effectiveness 
among cancer patients was calculated using a paired t-test and Wilcoxon signed ranks for 
chronic pain patients. Only observed data was used in all analysis; missing data was not 
imputed. 
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 Analysis was completed using SPSS 24. Ethical approval was not required, as the data 
were anonymized and collected as part of routine care. The project was registered with the 
relevant NHS Trust. 
Results 
Sample Characteristics 
 Both MI-call and no-MI groups were predominantly female with a mean age of 55 in 
both groups (Table 1). In both MI-call and no-MI cohorts, patients with breast cancer were 
the largest cancer sub-group. Baseline FACT-G7 and CPAQ scores in both groups indicated 
impaired quality of life among cancer patients and low pain acceptance among chronic pain 
patients. Both baseline scores in MI-call and no-MI groups were approximately one standard 
deviation below the mean by comparison to normative reference data (McCracken et al., 
2004; Yanez et al., 2012). Baseline FACT-G7 scores were significantly higher in the MI-call 
group (Z = 2.88, p = .004), which was controlled in cancer patient sub-analyses. There were 
no other significant demographic or clinical differences between groups. 
Group Attendance 
 In absolute terms, those within the no-MI group attended a mean 5.3 sessions (SD = 
2.3) and those within the MI-call group attended a mean 6.3 sessions (SD = 1.7).  Using the 
established criterion of attendance at four group sessions to categorize group completion, 
there were 14 dropouts (27%) in the no-MI group and 4 (9%) in the MI-call group. 
Group Completion 
 Regressing MI-call/no-MI on group completion indicated that the odds of completing 
the group programme were 5 times greater for patients in the MI-call cohort versus no-MI 
cohort controlling for age, gender and diagnosis (Table 2). There were no differences in 
effect between MBCT (ORadjusted = .95, 95% CI = .27 – 3.35, p = .940), PST (ORadjusted = 
.1.05, 95% CI = .30 – 3.71, p = .940) and ACT (ORadjusted = .1.68, 95% CI = .39 – 7.24, p = 
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.488) groups. Bootstrapped one-way ANCOVA indicated significantly greater session 
attendance in the MI-call group compared to no-MI (F [1, 94] = 5.44, p = .020, d = 0.47 [95% 
CI 0.06, 0.88]) when controlling for age, gender, and diagnosis. The estimated marginal 
mean-difference (.98 [95% CI 0.10, 1.80]) indicated that those in the MI-call group attended 
one additional group session per participant compared to those in the no-MI group. 
Cancer Diagnosis Completion 
 In a diagnosis level sub-analysis of group completion, the difference in favour of MI-
call amongst cancer patients (n = 68) increased when controlling for baseline cancer-related 
quality of life (ORadjusted = 10.0, 95% CI = 1.80 – 55.80, p = .009) and increased further if age 
and gender were also controlled (ORadjusted = 11.20, 95% CI = 1.9 – 65.81, p = .009). 
Similarly, there was a greater difference in number of sessions attended (favouring the MI-
call group) when limiting the bootstrapped ANCOVA model to cancer patients and entering 
baseline cancer-related quality of life as an additional covariate (F [1, 63] = 4.95, p = .013, d 
= 0.61 [95% CI 0.11, 1.11]; estimated marginal mean-difference = 1.245 [95% CI .21, 2.22]). 
As baseline CPAQ data were only available for 15 of the pain group attendees, similar sub-
analysis could not be performed.  
Clinical Effectiveness 
 Results of bootstrapped one-way ANCOVAs, controlling for baseline scores, 
indicated that there were no post-treatment differences in clinical outcomes between MI-call 
and no-MI groups, either in cancer (FACT-G7; F [1, 40] = 0.00, p = .965, d = 0.01 [95% CI -
0.61, 0.63]) or chronic pain (CPAQ; F [1, 7] = 2.13, p = .139, d = 0.82 [95% CI -0.72, 2.37]) 
– indicating that MI allocation did not affect clinical effectiveness. In terms of overall 
effectiveness across MI groups, there was a significant pre-post group improvement in 
cancer-related quality of life among cancer patients (Mdifference = 3.63, t(43) = 4.40, p <.001) 
with a moderate effect size (d = 0.63) and a mean difference exceeding the minimal clinically 
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important difference (Cella, Hahn, & Dineen, 2002). There was also a significant 
improvement in pre-post pain acceptance among chronic pain patients (Z = 2.08, p = .038) 
with a large effect size (d = 0.84). 
Discussion 
 This study indicates that a minimal-duration MI intervention can significantly 
increase adherence and reduce dropout in MBCT, PST and ACT groups for cancer and 
chronic pain patients. Results controlled for the effects of age, gender, diagnosis, group-type 
and baseline quality of life among cancer patients but were not able to control for baseline 
pain acceptance among chronic pain patients. There was no difference between groups in 
terms of clinical effectiveness, but potential differences could have been masked by the lack 
of follow-up for patients who dropped out. The routine care setting, pragmatic methods and 
low per-patient costs suggest the intervention could be implemented into clinical practice 
with minimal additional resource.  
Relationship to Existing Literature 
 Although MI has previously been used to prevent dropout, studies have typically 
incorporated several pre-treatment MI sessions or at least one hour long session with little 
clarity on what is required as a minimal duration for clinical effect (Palacio et al., 2016; 
Westra et al., 2016). This study confirms existing findings that MI is effective for reducing 
dropout (Oldham et al., 2012); the application of minimal-duration MI to MBCT, PST and 
ACT groups in cancer and chronic pain also extends current evidence. This study suggests 
dropout can be reduced using brief MI, even with health conditions that are likely to include 
severe physical impairments, either directly or as a result of related treatments (e.g. 
chemotherapy). Therefore, even where participating patients may have significant disability 
and demands associated with treatment that could prevent attendance, MI’s motivation 
enhancement may still have a clinical effect. This study also extends existing evidence by 
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evaluating a minimal duration of MI for clinical effect: a 15-minute, one-off structured 
telephone call. 
 The therapeutic processes in MI focus on eliciting and strengthening motivation for a 
targeted change (Miller & Rollnick, 2012). This study suggests that the impact of this type of 
conversation can take effect very quickly. Furthermore, this study indicates that personal 
motivations play a significant role in psychological therapy dropout, even when patients have 
physical limitations that could independently prevent attendance. 
Strengths  
The routine care setting for this study is a key strength in terms of practical 
implementation. This study gives a more reliable estimate of dropout from MBCT, PST and 
ACT groups in a clinical practice population and setting, which can be significantly worse 
than rates reported in controlled trials (Hansen et al., 2002; NHS Digital, 2018). This study 
also gives a practical, service-level example of how a brief MI intervention could be applied 
in a clinical psychology service. Although future research should investigate this study’s sub-
groups (e.g. ACT for chronic pain separate from MBCT for cancer), this study presents a way 
of implementing an intervention across diagnostic categories in a practicable way for clinical 
psychology services. Overall, this study presents a pragmatic methodology using minimal 
clinical resources. 
Limitations 
The cohort study design employed means that differences between cohorts cannot be 
ruled out. In particular, the no-MI cancer group had significantly poorer quality of life at 
baseline. Nonetheless, a significant effect remained for the MI-call group when controlling 
for quality of life and there were no other significant differences in clinical or demographic 
characteristics assessed. The no-MI cohort was also drawn from earlier groups for each 
therapy-type, which puts the study at risk of temporal differences unrelated to the MI call. 
REDUCING DROPOUT IN CANCER AND PAIN                                                               18 
For example, therapists may have become better at identifying and engaging patients at risk 
of dropout in later groups, due to greater experience of running the programs.  
As data were collected in routine care, rather than a controlled research setting, only 
pre-post treatment outcomes were collected from those attending group sessions and 
outcomes of those who dropped out were not collected. This limits the reliability of findings 
for MI-call’s clinical effectiveness. Firstly, those who dropout of cognitive behavioural 
therapies early are more likely to have poorer outcomes (Clark et al., 2009). Therefore, the 
larger proportion of patients unavailable to give outcome assessments in the no-MI group are 
likely to have had poorer outcomes. Therefore, the outcome comparison given may not be 
sufficiently balanced. Secondly, the beneficial effects of MI in MBCT, PST and ACT groups 
may not be evident until several months after treatment is completed. For example, Westra et 
al. (2016) found that MI integrated with CBT (MI-CBT) did not differ in effectiveness from 
CBT alone directly after treatment for generalized anxiety, but significantly greater benefits 
were apparent for MI-CBT at one-year follow-up. Therefore, pre- and post-treatment 
outcome assessment may be insufficient to evaluate the clinical effects of MI in this study. 
The sample size for ACT groups in chronic pain was too small to control for the effect of 
baseline pain acceptance on dropout and attendance. Therefore, it is possible that baseline 
differences between groups could have explained differences in dropout and attendance rates. 
However, no differences in attendance were found between cancer and pain, suggesting 
similarly-sized effects of MI for cancer and chronic pain. 
Future Research 
 This study suggests that randomized controlled trials of a minimal-duration MI 
intervention are warranted to assess the effect on dropout from MBCT, PST and ACT groups 
in cancer and chronic pain. Future research should be designed with greater specificity, to 
separately investigate different diagnostic groups and different CBT group-types. Such 
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studies should include follow-up for patients who drop out and extend outcome assessments 
several months beyond the end of treatment, to clarify whether MI has a longer-term effect on 
outcome among cancer and chronic pain patients in the same way as generalized anxiety. 
Future research should also investigate the cost effectiveness of a minimal-duration MI 
intervention, as this study is unable to quantify this effect. Current evidence for MI integrated 
with CBT suggests a potential benefit for having the same therapist for both MI and the 
following therapy (Westra et al., 2009; Westra et al., 2016). However, the current study did 
not contribute to this type of evidence. Future research could investigate differential effects of 
having the same or different therapists perform MI calls and CBT groups. There is also the 
possibility that dropout prevention could be enhanced in CBT groups for chronic health 
conditions other than pain and cancer, which could be investigated in future. 
Conclusion  
 Overall, this study indicates that even a 15-minute structured MI telephone call can 
have a significant effect on dropout from MBCT, PST and ACT groups in cancer and chronic 
pain. Given the purported mechanisms of MI, this suggests that eliciting an individual’s own 
good reasons for attending a potentially challenging psychological intervention can be 
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Table 1. 
Demographic and clinical characteristics of MI-call and no-MI groups. 
Demographics 
No-MI MI-call 
(n = 52)  (n = 47) 
Females 36 (69%) 39 (83%) 
Mean age (SD) 55 (10) 55 (10) 
Clinical Characteristics     
Cancer diagnosis 36 (69%) 37 (79%) 
Cancer site (% within cancer)   
Breast 15 (29%) 19 (40%) 
Lower Gastro-intestinal 6 (12%) 4 (9%) 
Haematology 3 (6%) 5 (11%) 
Head and Neck 3 (6%) 5 (11%) 
Brain 2 (4%) 1 (2%) 
Gynaecology 0 3 (6%) 
Urology 2 (4%) 1 (2%) 
Lung 2 (4%) 0 
Upper Gastro-intestinal 2 (4%) 0 
Hepatobiliary 0 1 (2%) 
Chronic Pain diagnosis 16 (31%) 10 (21%) 
Baseline FACT-G7 (SD) 10.0 (4.5) 14.1 (5.8) 
Baseline CPAQ (SD) 58.0 (28.8) 37.1 (19.2) 
Note. MI, Motivational Interviewing; SD, Standard Deviation; FACT-G7, Functional Assessment of Cancer 
Treatment – General 7-items; CPAQ, Chronic Pain Acceptance Questionnaire. 
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Table 2. 
Logistic regression of group completers versus dropouts predicted by MI-call versus no-MI 
Parameter B SE Wald p Adjusted OR 
95% CI 
Lower Upper 
MI calling  1.56 0.63 6.02 .014 4.74 1.37 16.40 
Age -0.04 0.03 2.03 .155 0.96 0.91 1.02 
Gender -0.66 0.71 0.85 .358 0.52 0.13 2.10 
Diagnosis (0 = pain 1 = cancer) 0.52 0.75 0.48 .488 1.68 0.39 7.24 
Constant 3.67 2.00 3.35 .067 39.19 
    
Note. Abbreviations: B, beta coefficient; SE, standard error; p, significance with alpha .05; OR, odds ratio; CI, confidence interval. 
 
